Nasal Sprays Recalled Due To Risk of Coma, Death

On August 5, 2020, Ferring Pharmaceuticals recalled three nasal sprays due to superpotency. These nasal sprays are used to help regulate renal (kidney) water conservation in people with certain conditions. The recalled sprays are DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. According to the recall, these products are being recalled because testing revealed the presence of higher than specified amounts of a drug called desmopressin. Desmopressin in higher than specified amounts is associated with abnormally low levels of sodium in the blood (hyponatremia), which could cause seizure, coma, or death.

The recalled nasal sprays are used as an antidiuretic replacement therapy in some patients with central cranial diabetes insipidus or patients with abnormal urination or thirst after a head trauma or surgery in the pituitary region. Additionally, STIMATE is also used in some patients with certain types of bleeding disorders (hemophilia A and Von Willebrand disease).

According to the recall, Ferring Pharmaceuticals is notifying its distributors and wholesale customers directly, instructing them to return unused product affected by the recall. For a list of the recalled lots of these nasal sprays and more information regarding the recall, click here.

Unfortunately, this recall is not the first regarding a potentially dangerous, superpotent drug. If you or a loved one have been seriously injured due to the recalled nasal sprays or another defective drug, the Cincinnati product liability attorneys at Burg Simpson can help. Burg Simpson has successfully represented thousands of individuals who suffered injuries due to defective products, including superpotent drugs. Burg Simpson’s product defect lawyers hold companies responsible for their defective products, and will fight to secure just compensation for those injured by them. Call Burg Simpson’s Cincinnati defective product attorneys today at 513-852-5600 or fill out our free case evaluation form now to discuss your case with us.